Cinchona officinalis
What's the taxonomical classification of Cinchona officinalis?
Cinchona officinalis belongs to the kingdom Plantae and is categorized under the phylum Streptophyta. Within this group, it is classified under the class Equisetopsida and the subclass Magnoliidae. Following the taxonomic hierarchy further, it falls under the order Gentianaales and the family Rubiaceae. Finally, the plant is identified by its genus, Cinchona, and its specific species, officinalis.
| Taxonomic Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Gentianales |
| Family | Rubiaceae |
| Genus | Cinchona |
| Species | officinalis |
What are the morphological characteristics of this plant?
Cinconan officiinalis has an erect, woody stem that grows into a medium-sized tree reaching heights of up to 10 meters with simple, opposite leaves that are elliptical or oblong in shape. The leaf margins are typically entire, and the surface often displays a glossy texture with prominent pinnate venation. Small, tubular white or pinkish flowers emerge in terminal cymes, which eventually develop into small, fleshy drupes containing seeds. The bark is thick and brownish, serving as the primary source for quinine extraction. These structural characteristics allow the plant to thrive in tropical rainforest environments.
What is the geographical distribution of this plant?
This plant is native to the humid tropical montane forests of the Andes Mountains in South America, specifically spanning across countries such as Peru, Ecuador, and Colombia. It thrives primarily at high elevations where the climate remains consistently moist and temperate. Within these mountainous ecosystems, the species occupies specific ecological niches characterized by rich soil and significant rainfall. While its natural range is strictly limited to these South American highlands, its historical importance led to various attempts at introduction in other tropical regions. Understanding this specific distribution is essential for studying the plant's natural habitat requirements.
How is this plant cultivated?
This plant Cinchona officinalis is cultivated in tropical and subtropical highland regions with well-drained, acidic soils and high humidity to optimize bark production.
Growers typically plant seeds in shaded nurseries before transplanting the saplings into permanent plantations once they are established. Regular maintenance requires careful monitoring of rainfall patterns and the prevention of soil erosion on hilly terrains. The trees are often grown in polycultures to maintain biodiversity and soil health.
After several years of growth, the bark is harvested by stripping it from the trunk and branches to extract quinine.
What parts of this plant are used medicinally?
Cincona officinalis contains medicinal alkaloids primarily extracted from the dried bark of its stem and roots. The most significant component found within this bark is quinine, which has been used historically to treat malaria. Beyond quinine, the plant also yields other valuable alkaloids such as cinchonine, cinchonidine, and cinchonine. These chemical compounds work by interfering with the lifecycle of parasites in the bloodstream. Harvesting the bark is a careful process to ensure the plant can continue to grow while providing sufficient medicinal material.
What are the pharmacological activities of Cinchona officinalis?
This plant has potent anti-malarial, antiparasitic, antiplasmodial, antimicrobial, and antibacterial pharmacological activities. Its most famous alkaloid, quinine, serves as a primary treatment for malaria by targeting the parasite within the bloodstream. The chemical constituents also demonstrate significant antiplasmodial properties that combat blood-borne protozoa. Furthermore, the various alkaloids extracted from the bark exhibit broad antimicrobial effects against various pathogens. These diverse biological actions make the species a vital source for treating both parasitic infections and bacterial ailments.
According to a study published by "Current topics in medicinal chemistry", the cinchona alkaloid cinchonine is commercially extracted from the Peruvian bark of Cinchona officinalis L. This compound has been historically used as an anti-malarial agent and possesses various biological properties, including anti-cancer, anti-obesity, anti-inflammatory, anti-parasitic, antimicrobial, anti-platelet aggregation, and anti-osteoclast differentiation activities. It induces anti-cancer activity by activating caspase-3 and PARP-1, which triggers the endoplasmic reticulum stress response through the up-regulation of GRP78 and the phosphorylation of PERK and ETIF-2α. Furthermore, cinchonine inhibits osteoclastogenesis by inhibiting TAK1 activation and suppressing NFATc1 expression through the regulation of AP-1 and NF-κB. These pharmacological effects make it a promising compound for various therapeutic applications.
The primary pharmacological activities of this plant are shown in the list below.
- anti-malarial
- antimalarial
- antiparasitic
- antiplasmodial
- antibacterial
What medicinal compounds this plant contains?
This plant contains several key alkaloids, most notably quinine, quinidine, cinchonine, and cinchonidine. Quinine is the most significant compound because it serves as a powerful antimalarial agent used to treat infections caused by Plasmodium parasites. Quinidine is another essential derivative frequently utilized in medicine to manage cardiac arrhythmias by regulating heart rhythms. The other alkaloids, cinchonine and cinchonidine, are often studied for their specific chemical properties and potential biological activities. Together, these medicinal compounds have historically revolutionized the treatment of tropical diseases and cardiovascular conditions.
What health conditions is this plant used for?
This plant is used for the treatment of malaria, various infectious diseases, and different infections of microbial origin. The bark of Cinchona officinalis contains quinine, which serves as a vital medicinal component for managing parasitic illnesses. Recent scientific investigations have also explored its potential applications in addressing the SARS-CoV-2 infection. Researchers study these bioactive compounds to see if they can mitigate the complications associated with COVID-19. This ongoing research highlights the enduring importance of botanical resources in modern pharmacology.
According to a study published by "Journal of complementary & integrative medicine", Cinchona officiinalis (Chin.) 30C is used in combination therapy to evaluate efficacy against lethal murine malaria caused by Plasmodium berghei. In experiments involving five groups of twelve BALB/c mice, the combination containing Chin. 30 exhibited complete parasite clearance by the 28th day post-inoculation. This treatment resulted in an enhanced mean survival time of 28±0 days, compared to the infected control group which survived only 7.6±0.4 days. The combination demonstrated a significant preventive activity with 89.2% chemosuppression, which was higher than the 83.8% achieved by pyrimethamine. Additionally, the treatment showed moderate curative activity with complete parasite clearance in 50% of surviving mice and an enhanced mean survival time of 26.8±2.8 days.
The main health conditions this plant is used for are shown in the list below.
- malaria
- infectious diseases
- infections of microbial origin
- COVID-19
- SARS-CoV-2 infection
What are the herbal preparations of this plant?
This plant can be prepared as a decoction of bark by boiling the dried material in water to extract its bitter alkaloids. A tincture of bark is also commonly produced by soaking the bark in alcohol to create a concentrated liquid solution. For more direct administration, the powdered bark can be mixed into food or beverages to facilitate ingestion. Additionally, a concentrated extract is often manufactured to ensure a standardized dose of quinine. These various forms allow for the medicinal properties of the plant to be utilized in diverse therapeutic applications.
The main herbal preparations of this plant are shown in the list below.
- Decoction of bark
- Tincture of bark
- Powdered bark
- Extract
What side effects this plant can have?
This plant can cause a wide range of adverse reactions including nausea, vomiting, dizziness, tinnitus, headache, visual disturbances, abdominal pain, diarrhea, palpitations, hypoglycemia, convulsions, and cardiac arrhythmias. These side effects often arise from the presence of quinine, which can impact the central nervous and cardiovascular systems. Patients may experience gastrointestinal distress such as abdominal pain and diarrhea alongside neurological symptoms like headaches or blurred vision. Serious complications can include dangerous heart rhythm changes known as cardiac arrhythmias or sudden drops in blood sugar. In severe cases, individuals might suffer from life-threatening issues like convulsions.
The main side effects this plant can have are shown in the list below.
- Nausea
- Vomiting
- Dizziness
- Tinnitus
- Headache
- Visual disturbances
- Abdominal pain
- Diarrhea
- Palpitations
- Hypoglycemia
- Convulsions
- Cardiac arrhythmias